We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DEC
1626
Diversified Energy Company
DEC
$1.07B
| $58K | ﹤0.01% |
3,956
-4,048
| -51% | -$54.2K |
|
1627
IDEX
IEX
$17.2B
| $57.8K | ﹤0.01% |
329
-4
| -1% | -$709 |
|
1628
Dycom Industries
DY
$9.25B
| $57.7K | ﹤0.01% |
236
-256
| -52% | -$50.4K |
|
1629
iShares Russell 3000 ETF
IWV
$20.4B
| $56.2K | ﹤0.01% |
160
-4,682
| -97% | -$1.52M |
|
|
PSTL
1630
Postal Realty Trust
PSTL
$708M
| $55.5K | ﹤0.01% |
3,770
+3,470
| +1,157% | +$47.6K |
|
1631
UDR
UDR
$11.9B
| $53.6K | ﹤0.01% |
1,312
-11
| -0.8% | -$456 |
|
|
XYZ
1632
Block Inc
XYZ
$51B
| $53.3K | ﹤0.01% |
784
-398,528
| -100% | -$23.2M |
|
|
HLVX
1633
DELISTED
HilleVax
HLVX
| $52.7K | ﹤0.01% |
26,467
+2,038
| +8% | +$3.73K |
|
1634
Akamai
AKAM
$16B
| $50.7K | ﹤0.01% |
636
-1,317
| -67% | -$102K |
|
1635
Viatris
VTRS
$19.4B
| $49.7K | ﹤0.01% |
5,566
-4,209
| -43% | -$35.6K |
|
1636
Clarus
CLAR
$144M
| $49.7K | ﹤0.01% |
14,317
-203
| -1% | -$688 |
|
1637
Supernus Pharmaceuticals
SUPN
$2.57B
| $49.5K | ﹤0.01% |
1,572
-13
| -0.8% | -$417 |
|
1638
El Pollo Loco
LOCO
$463M
| $49.3K | ﹤0.01% |
4,479
| – | – |
|
1639
News Corp Class A
NWSA
$16.8B
| $48.8K | ﹤0.01% |
1,641
-20
| -1% | -$550 |
|
1640
Enova International
ENVA
$5.91B
| $48.6K | ﹤0.01% |
436
+130
| +42% | +$12.4K |
|
1641
American States Water
AWR
$3.52B
| $46.5K | ﹤0.01% |
607
+98
| +19% | +$7.69K |
|
1642
Zentalis Pharmaceuticals
ZNTL
$367M
| $46.1K | ﹤0.01% |
39,736
-712,781
| -95% | -$940K |
|
1643
Argan
AGX
$6.45B
| $46.1K | ﹤0.01% |
209
+10
| +5% | +$1.8K |
|
1644
Solventum
SOLV
$15.5B
| $45.8K | ﹤0.01% |
604
-160
| -21% | -$11.3K |
|
1645
WesBanco
WSBC
$3.88B
| $45.4K | ﹤0.01% |
1,435
+600
| +72% | +$18.1K |
|
1646
Universal Health Services
UHS
$10.2B
| $45.1K | ﹤0.01% |
249
-9
| -3% | -$1.62K |
|
1647
Boston Properties
BXP
$11.2B
| $44.9K | ﹤0.01% |
666
-22
| -3% | -$1.47K |
|
1648
ABM Industries
ABM
$2.76B
| $43.4K | ﹤0.01% |
920
| – | – |
|
1649
Mercury Systems
MRCY
$5.44B
| $43.1K | ﹤0.01% |
+801
| New | +$39K |
|
1650
Origin Bancorp
OBK
$1.64B
| $41.8K | ﹤0.01% |
1,169
+17
| +1% | +$563 |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.